Recent experimental evidence indicates that some cancer cells have an alternative glycolysis pathway with net zero ATP production, implying that upregulation of glycolysis in these cells may not be related to the generation of ATP. Here we use a genome-scale model of human cell metabolism to investigate the potential metabolic alterations in cells using net zero ATP glycolysis. We uncover a novel pathway for ATP generation that involves reactions from the serine biosynthesis and one-carbon metabolism pathways. This pathway has a predicted two-fold higher flux rate in cells using net zero ATP glycolysis than those using standard glycolysis and generates twice as much ATP with significantly lower rate of lactate-but higher rate of alanine secretion. Thus, in cells using the standard-or the net zero ATP glycolysis pathways a significant portion of the glycolysis flux is always associated with ATP generation, and the ratio between the flux rates of the two pathways determines the rate of ATP generation and lactate and alanine secretion during glycolysis.
Introduction
Oxidative phosphorylation (OxPhos) in the mitochondria is the major pathway for ATP generation in normal cells under normal oxygen conditions (normoxia), generating 32 mole of ATP per mole of glucose [1] . In contrast, under conditions of oxygen limitation (hypoxia), the mitochondrial activity is down-regulated and cells switch to glycolysis for ATP generation that yields only 2 mole of ATP per mole of glucose. Surprisingly, as first observed by Warburg [2] , the metabolism of cancer cells is frequently characterized by a significant upregulation of glycolysis even under normoxic conditions, with both an increased glucose uptake and excretion of lactate (Warburg effect) . More recently, it became evident that the Warburg effect is not unique to cancer cells alone. Indeed, both rapidly proliferating normal cells [3, 4, 5, 6, 7, 8] and nonproliferating cells with high metabolic activity [9, 10, 11] display high levels of glycolysis with lactate excretion under normoxic conditions.
Despite the importance of OxPhos and aerobic glycolysis in ATP generation, more recent empirical evidence indicates that some cancer cells also utilize an alternative glycolysis pathway with net zero ATP generation [12] . This striking observation implies a physiological role for aerobic glycolysis other than ATP generation. One such role may be the capacity of glycolysis to fulfill the need of rapidly proliferating cells for precursor metabolites. However, it has been shown previously that the need for precursor metabolites in itself is not sufficient to explain the high glycolysis rates observed in proliferating cells [13, 14] . Instead, molecular crowding and its resulting constraint on macromolecular concentrations is the key factor determining the Warburg effect [14, 15] . The high density of macromolecules in the cell imposes limits on the total mitochondrial content per unit of cell volume and the total content of metabolic enzymes as well. In turn, the inherent limitation in mitochondrial density results in an upper bound on the maximum achievable OxPhos capacity. We have shown previously that this maximum is achieved at physiological conditions and that it results in a metabolic switch involving an upregulation of glycolysis and lactate excretion [14, 15] . Yet, all these results were obtained making use of the standard glycolysis pathway, with a yield of 2 moles of ATP per mole of glucose.
Here we investigate the metabolic flux redistributions in proliferating cells that utilize the alternative glycolysis pathway with net zero ATP production [11] . To this end we improve on our previous flux balance model of human cell metabolism [14] by more precisely accounting for protein synthesis, including a self-consistent constraint that all ribosomal-, enzyme associated-, and non-metabolic proteins need to be accounted for by the rate of protein synthesis, which is proportional to the ribosomal density. We also make a more precise accounting of the molecular crowding constraint by considering mitochondria as a subcellular compartment independent from the cytosol. Using this model we uncover a novel pathway for ATP generation that involves reactions in the serine biosynthesis and one-carbon metabolism pathways. The flux rate of this pathway is predicted to be two-fold higher in cells with net zero ATP glycolysis relative to cells with the standard glycolysis. Furthermore, it accounts for most of the glycolysis rate in cells with net zero ATP glycolysis.
Results

Flux balance model of cell metabolism with molecular crowding constraint
As starting point, we utilize a genome-scale metabolic reconstruction of a generic human cell [16] that includes most biochemical reactions catalyzed by enzymes encoded in the human genome. We add auxiliary reactions to represent nutrient uptake, excretion of metabolic byproducts, basal ATP demand needed for cell maintenance, basal rate of protein degradation, synthesis of cell biomass components (proteins, lipids, RNA and DNA) and cell proliferation (biomass components ! cell) (Table S1 , http://cinjweb.umdnj.edu/~vazqueal/fba_human.html). We assume that the cell is in a steady state where the production and consumption of every metabolite and macromolecules balances, known as the flux balance constraint [17] . We use f i to denote the steady state reaction rate (flux) of the i-th reaction in the metabolic network, where all reversible reactions are represented by a forward and backward rate, respectively. We use ! c to denote the relative cell volume fraction occupied by the c-th cellular compartment, where a compartment represents the overall contribution of macromolecules of certain type (e.g., ribosomes) or of certain cell organelle (e.g., mitochondria). Specifically, here we consider proteins that do not form part of enzyme complexes or ribosomes (P0) and nutrients uptake systems (NU), all metabolic enzymes catalyzing reactions outside the mitochondria (EnM), all metabolic enzymes catalyzing reactions in the mitochondria (EM), ribosomes (R), and mitochondria (M). We assume the proliferation rate (µ) and the total relative volume fraction occupied by macromolecules and organelles (! max ) are known and are given as input parameters of the model. Finally, we estimate the metabolic fluxes and compartment densities as the solution of the following optimization problem:
Find the f i and ! c that minimize the sum of nutrient uptake rates (1) " i|NU f i subject to the metabolic constraints
where S mi is the stoichiometric coefficient of metabolite m in reaction i, a i =v i /k eff,i are the crowding coefficients of metabolic enzymes (enzyme molar volume / enzyme effective turnover) [18] , a R =v R /k R is the ribosome crowding coefficient (ribosome molar volume / protein synthesis rate per ribosome), and a M,ATP =v s,M /r M the crowding coefficient of mitochondria ATP generation (ATP synthesis rate per mitochondria mass / mitochondria specific volume) [14, 15] .
The estimation of all the model parameters is presented in the Methods section. Here we discuss some of them that deserve particular attention. The effective turnover numbers k eff,i , quantify the reaction rate per enzyme molecule. For example, for an irreversible single substrate reaction satisfying Michaelis-Menten kinetics, k eff =kS/(K+S), where k is the enzyme turnover number, K the half-saturation concentration and S the substrate concentration. The turnover numbers of some human enzymes are reported in the BRENDA database [19] . They have a typical value of 10 sec -1 and a significant variation from 1 to 100 sec -1 (Table S2 , http://cinjweb.umdnj.edu/~vazqueal/fba_human.html). However, for most reactions we do not know the turnover number, the kinetic model, or the metabolite concentrations, impeding us to estimate k eff . To cope with this indeterminacy we performed a sampling strategy, whereby the k eff,i were sampled from a reasonable range of values, and then focused on the predicted average behavior and 90% confidence intervals. The typical enzyme crowding coefficient is about a i~0 .00013 (mM/min) -1 , which is interpreted as follows: to maintain a reaction rate of 1 mM/min we need to allocate a relative cell volume of 0.00013 (0.013%) for the corresponding enzyme. The crowding coefficients are significantly larger for ribosomes and the mitochondria: a R =3.6 (mM/min) -1 and a M,ATP =0.017 (mM/min) -1 , respectively.
The flux balance equation for proteins (equation (2) with m=proteins) is formulated more generally than before. Previous models have assumed a constant protein concentration and have not taken into account the self-consistent need to synthesize all the proteins in enzyme complexes and ribosomes [13, 14] . In contrast, here we account for three major categories, proteins not associated with metabolism, proteins that are components of enzyme complexes, and ribosomal proteins, with their concentrations (moles/cell volume) denoted by P 0 , P E , and P R , respectively. In proliferating cells, these concentrations will decrease at a rate (µ+k D )(P 0 +P E +P R ), where µ denotes the proliferation rate and k D the basal rate of protein turnover. The total concentration of proteins in enzyme complexes can be estimated as P E =n PE E=n PE " i f i /k eff,i , where n PE is the average number of proteins in an enzyme complex (about 2.4) and E is the total concentration of metabolic enzymes. Similarly, P R =n PR ! R /v R , where n PR is the number of proteins in a ribosome (82 for the 80S ribosomes) and ! R /v R is the concentration of ribosomes. Putting all these elements together, the balance between protein turnover and synthesis implies f Protein_sysnthesis 
, where the term (µ+k D )P 0 is the only one considered in previous models [13, 14, 17] . In an effective manner, each metabolic reaction contributes to a component of protein synthesis, with a stoichiometric coefficient (µ+k D )n PE /k eff,i , quantifying the amount of protein necessary to keep the concentration of the corresponding enzyme constant. Similarly, a constant ribosome volume fraction also accounts for a component of protein synthesis, with a stoichiometric coefficient (µ+k D )n PR /v R , quantifying the amount of protein necessary to keep the ribosomes concentration constant. The rate of protein synthesis accounting for this effective protein dilution/degradation thus models the autocatalytic nature of cell metabolism, whereby the macromolecular complexes catalyzing the metabolic reactions ultimately are themselves a product of metabolism.
To model the alternative glycolysis pathway we replaced the pyruvate kinase catalyzed reaction: Phosphoenolpyruvate + ADP + H + ! Pyruvate + ATP, by the ATP independent reaction: Phosphoenolpyruvate + H + ! Pyruvate + Phosphate. In the latter reaction phoshoglycerate mutase (PGM1) is the phosphate acceptor, which is then dephosphorylated by a yet unknown mechanism [12] . Figure 1 shows the predicted relative volume fraction occupied by non-mitochondrial enzymes (! EnM =" i|EnM a i f i ), mitochondria (! M ), and ribosomes (! R ) as a function of the proliferation rate for cells growing in a medium containing glucose, glutamine, essential amino acids, and oxygen. The ribosomal density increases monotonically with increasing the proliferation rate in a nonlinear fashion, reaching a maximum of 10% of the cell volume at the highest proliferation rate of about 3/day (minimum doubling time of ln(2)/µ max =5.5 hours) ( Fig. 1 , blue circles). At low proliferation rates, the mitochondrial density exhibits a wide range of values, overall occupying ~ 20% of the cell volume, and initially it increases with increasing the proliferation rate ( Fig. 1, green triangles) . However, beyond a proliferation rate of about 0.8/day (doubling time 21 hours), the mitochondrial density decreases with increasing the proliferation rate. This is in turn accompanied by a dramatic increase in the density of metabolic enzymes ( Fig. 1 , red squares). Our model thus predicts that when switching from low to high proliferation rates, the cell makes a transition from a mitochondria dominated molecular crowding regime to one dominated by enzymes + ribosomes (Fig. 1 ).
Changes in the relative macromolecular densities with increased cell proliferation
The impact of altering the different model parameters used on the behavior of the model can also be tested. Larger values of the mitochondrial crowding coefficient a M , e.g., due to a decrease in mitochondrial efficiency for ATP generation, will cause a decrease of mitochondrial density at lower proliferation rates. Larger ribosome crowding coefficient a R , e.g., due to a decrease in protein synthesis efficiency, will result in a faster increase of the ribosome density with increasing the proliferation rate, and a consequently faster decrease of the mitochondria density. Similarly, an increase in the average crowding coefficient of metabolic enzymes will cause a faster increase of the total enzyme concentration with increasing the proliferation, resulting in a faster decrease of the mitochondrial density as well. Cancer cells are characterized by partial alterations in all of these components, potentially resulting in a more dramatic effect than that depicted in Figure 1 . In particular, mutations leading to damaged mitochondria will enhance the effect, as originally hypothesized by Warburg [2] .
Metabolic switch from low-to high proliferation rates
The predicted transition in the macromolecular composition of the cell is accompanied by a global switch in the cell's metabolic state (Fig. 2) . At the proliferation rate of about 0.8/day (doubling time 21 hours) the model predicts a substantial increase in glucose uptake, sudden activation of glutamine uptake and $-ketoglutarate dehydrogenase activity, complete deactivation of pyruvate decarboxylase (PCm) and activation of the enzyme, pyruvate dehydrogenase (PDHm). The activity of pyruvate carboxylase in the low proliferation regime, where there is no glutamine uptake, is consistent with recent experimental data showing that pyruvate carboxylase is needed for growth without glutamine [20] . The activation of glutamine uptake at high proliferation rates is also in agreement with what have been observed experimentally [21] . We also observe activation of lactate excretion at high proliferation rates, the hallmark of the Warburg effect.
Several notable changes take place around the pyruvate branching point (Fig. 2) . Most noticeably, the glycolysis pathway (Fig. 2 ) is truncated at 3-phosphoglycerate and the flux over the ATP-decoupled pyruvate kinase-catalyzed reaction is zero at all proliferation rates. We emphasize that we have not imposed a zero flux over this reaction, and the zero flux is a prediction of the model itself. Tryptophan is a source of pyruvate at low proliferation rates, with alanine as an intermediate metabolite (Fig. 2 , tryptophan to pyruvate route, dashed lines). Alanine is converted to pyruvate by alanine transaminase, with concomitant transformation of $-ketoglutarate to glutamate. However, at high proliferation rates this reaction is reverted, producing alanine instead, which is then excreted. At high proliferation rates pyruvate is instead generated from glutamine (via malate). The cytosolic-(LDH-L) and mitochondrial L-lactate dehydrogenases (LDH-Lm) form a cycle between pyruvate and lactate. At low proliferation rates, LDH-Lm converts pyruvate to lactate and LDH-L converts lactate back to pyruvate, both reactions working at the same rate (Fig. 2 , pyruvate-lactate loop, dashed lines). At high proliferation rates the cycle is reverted, LDH-L converting lactate to pyruvate and LDH-Lm pyruvate back to lactate (Fig. 2 , pyruvate-lactate loop, solid lines). In the latter case the LDH-Lm catalyzed reaction has a higher rate, resulting in the net production of lactate, which is then excreted.
To provide evidence that the metabolic switch is a direct consequence of the molecular crowding constraint, we repeated the in silico analysis after removing this constraint (mathematically setting ! max =% in equation (5)). Inspecting the changes in the reaction rates we observe that the metabolic switch it lost. The glucose uptake increases monotonically with increasing the proliferation rate (Fig. S1 ), but it does not manifest the same high rate of increase as with the molecular crowding constraint in place (Fig. 2) . Furthermore, there is no lactate excretion at any proliferation rate (Fig. S1 ).
Novel pathway for ATP generation
When considering the molecular crowding constraint, our simulations show that at high proliferation rates most of the glycolysis rate is diverted towards the biosynthesis of serine (Fig. 2) . However, this flux rate exceeds by more than 10 fold the serine requirements for protein synthesis (Fig. 2 , serine to protein synthesis, top center panel). Therefore, we hypothesized that cells utilizing the net zero ATP glycolysis may overexpress some alternative pathway for ATP generation. To test this hypothesis we inspected the genome-scale reaction rate predictions, focusing on reactions producing ATP. Following this approach we identified the reactions with high rates of ATP production in cells with a net zero ATP glycolysis at different proliferation rates. At low proliferation rates (0.03/day, doubling time 24 days) ATP synthase was the dominant reaction, supplying most of the ATP required for cell maintenance (Fig. 3a,b, left panels) . On the other hand, at high proliferations rates (2.52/day, doubling time 6.6 hours) the formate-tetrahydrofolate ligase (FTHFL), working in the reverse direction to form ATP, is the dominant reaction (Fig. 3a, right panel) . Formate-tetrahydrofolate ligase is also active in cells with the standard glycolysis (Fig. 3b, right panel) . However, in the case of standard glycolysis phosphoglycerate kinase and pyruvate kinase are the dominant reactions at high proliferation rates (Fig. 3b, right panel) .
By tracking back the flux from the formate-tetrahydrofolate ligase-catalyzed reaction to glycolysis we uncovered a novel pathway for ATP generation (Fig. 4) . The pathway is composed of three main steps. First, synthesis of L-serine (ser-L) from the glycolysis intermediate metabolite 3-phosphoglycerate (3pg), using NAD and L-glutamate (glu-L) as cofactors (Fig. 4a) , with the overall reaction
Second, the conversion of L-serine to glycine with a concomitant one-carbon metabolism cycle, resulting in the net generation of 1 mole of ATP per mole of serine transformed, using NADP as a cofactor (Fig. 4b) , with the overall reaction This pathway has a net yield of 2 mole of ATP per mole of 3-phosphoglycerate, therefore 4 mole of ATP per mole of glucose. Furthermore, when compared to the standard glycolysis, the net zero ATP glycolysis manifests a significant decrease in lactate excretion while increasing the alanine excretion (Fig. 2 a,b, right panel) Although the reactions in the reaction cycle shown in Fig. 4b are all annotated as reversible in the human metabolic network reconstruction [16] , the cycle may not work in the direction of ATP production due to thermodynamic constraints. Formatetetrahydrofolate ligase (FTHFL) can efficiently catalyze the synthesis of ATP in the bacterium Clostridium cylindrosporum [22] . However, it remains to be elucidated whether this is also feasible in human cells, where the tri-functional enzyme C 1 -tetrahydrofolate synthase is responsible for the methylene-tetrahydrofolate dehydrogenase (MTHFD), methenyl-tetrahydrofolate cyclohydrolase (MTHFC) and FTHFL activities. To address this issue, we have analyzed a kinetic model of the reaction cycle shown in Figure 4b , focusing on the cytosolic enzymes alone. The model is fully described in the Supporting Information and is based on a previous model of folate metabolism [23] . We demonstrate that the kinetic model has a stable steady state in the direction of ATP production, indicating that the novel pathway is thermodynamically feasible.
Discussion
The recent demonstration of an alternative glycolysis pathway with net zero ATP production in rapidly proliferating cells [12] challenged the general notion that the production of ATP is a major function of glycolysis. Instead, an alternative hypothesis suggests that the increased rate of glycolysis in rapidly proliferating cells is present to support the increased demand for precursor metabolites by anabolic processes involved in cell growth and proliferation [24] . However, based on a partial-or full genome-scale reconstruction of human cell metabolism [16, 17] containing the standard glycolysis pathway we [14, 15] and others [13] have shown that the anabolic requirements can be satisfied without the need for a dramatic upregulation of glycolysis and the excretion of lactate. We have recapitulated this result here, now using the alternative glycolysis pathway with net zero ATP production, providing in silico evidence that the demand for precursor metabolites can be satisfied without upregulation of the alternative glycolysis pathway (Fig. 2) .
We have shown previously that molecular crowding is a major determinant of the metabolic changes observed in highly proliferating mammalian- [14, 15] and prokaryotic cells [25, 26] and in quiescent cells with high energy demands [14] . In essence, the high density of macromolecules in the intracellular millieu results in a 'competition' among mitochondria, ribosomes, metabolic enzymes and structural protein for the available intracellular space. At low metabolic rates this constraint is less pronounced, and therefore the density of the required organelles and macromolecules can increase to accommodate the increasing metabolic rate. However, much as just a finite number of people can be placed in a room, we can just fit a finite amount of mitochondria in the cell, resulting in an upper bound for OxPhos capacity. To satisfy its energetic needs beyond this maximum OxPhos capacity the cell need to switch to other pathways that are less costly in terms of the required relative fraction to allocate the corresponding enzymes, such as the classic glycolysis pathway. However, this hypothesis has been challenged by the observation that highly proliferating cells utilize an alternative glycolysis pathway with net zero ATP production [12] . To resolve this contradiction we have improved our genome-scale metabolic model of a human cell to be able to investigate the consequences of a net zero ATP production glycolysis.
The results of our in silico analyses yield several surprising observations. The glycolysis flux is upregulated in highly proliferating cells and it is routed from 3-phosphoglycerate toward serine biosynthesis. This prediction is supported by recent experimental observations in highly proliferating cells. Rapidly proliferating cells during embryonic development and cancer cells express a splice variant of pyruvate kinase (PKM2) that has low catalytic activity for the conversion of phosphoenol pyruvate to pyruvate, effectively reducing the rate over the last steps of glycolysis [12, 27] . Serumstimulation of Rat1A fibroblasts proliferation results in an increased 13 C-labeled glycine derived from 3-phosphoglycerate, in a myc dependent manner [28] . In agreement with the latter observation, gene expression microarray analyses have reported up-regulation of enzyme-encoding genes that catalyze one carbon metabolism in cancer cells [29, 30] . These observations support the existence of an alternative glycolysis pathway with net zero ATP production and concomitant up-regulation of serine biosynthesis and onecarbon metabolism.
Our in silico approach allow us to investigate the fate of the high rate of the serine biosynthesis pathway. We discover that its final endpoint is a novel pathway for ATP generation, starting from the biosynthesis of serine and involving reactions in the onecarbon metabolism pathway (Fig. 4) . The reaction responsible for the net ATP generation is catalyzed by formate-tetrahydrofolate ligase (EC 6.3.4.3), working in the ATP production direction. This pathway has a yield of 2 mole of ATP per mole of 3-phosphoglycerate, or 4 moles of ATP per mole of glucose. Taken together our in silico evidence indicates that, even in the context of an alternative glycolysis pathway with net zero ATP production, glycolysis is upregulated to satisfy the high energy demand of highly proliferating cells, during conditions where molecular crowding imposes a bound or a reduction in the mitochondrial density.
The novel pathway doubles the ATP yield from 2 to 4 mole of ATP per mole of glucose (Table I ). The novel pathway requires, however, the balance of several co-factors and thus it is coupled to several other reactions. Yet, it remains to be elucidated what the potential evolutionary advantage of having two alternative glycolysis pathways is (i.e., the net zero ATP and the standard pathways) . As we show here, the novel pathway can generate two times more ATP, thus an energetic reason is probably likely. In contrast, the novel pathway involves 17 reactions, 7 more than the standard glycolysis, potentially contributing more to molecular crowding. Taken together with OxPhos, we obtain a hierarchy in terms of ATP yield: OxPhos >> net-zero-ATP-glycolysis > standardglycolysis, and the same hierarchy in terms of molecular crowding. Therefore, these pathways provide the cell with different alternatives to cope with competing efficiency principles, ATP yield per mole of substrate or ATP yield per occupied volume fraction. Concomittantly, other factors, such as the cellular lactate and alanine production also has several potential advantages on the population level that may enhance the invasiveness of tumor cells. Also, tumor cells frequently encounter fluctuating hypoxia levels within growing tumors [31] requiring a capability to rapidly deploy alternative metabolic strategies [32] . In any event, our model identifies several metabolic changes that can be subject to further theoretical and experimental investigations. Table S2 ). In the simulations log10(k i ) was sampled uniformingly from the interval log10(1/sec) to log10(100/sec). Simulations: The optimization problem in equations (1)- (5) was solved in Matlab, using the linear programming function linprog. All reversible reactions were represented by an irreversible reaction on each direction with their own turnover number k i . Most flux bounds were set to v i,min =0 and v i,max =%, unless specified otherwise (Table S1) .
Kinetic model: The kinetic model is described in the Supplementary Information. d
Our aim is to determine whether this dynamical system has a steady state with in the direction of producing ATP.
To this end we numecarically determined the fixed point of (5)- (8) that resulted in the highest steady state flux with ATP production. This was accomplished solving the optimization problem:
subject to the fixed point constraints
and the metabolite concentration bounds
The problem was solved in Matlab using the function fmicon, with all upper bounds equal to 1 mM. For all 0 < E SMT HF D1 /(E SHMT + E SMT HF D1 ) < 1 the steady state with maximum rate is characterized by a positive rate of ATP production (Fig. S2, green cicrles) , indicating that the reaction cycle shown in Figure 4b is thermodynamically feasible in the direction of ATP production. The maximum rate is achieved at a relative concentration E SMT HF D1 /(E SHMT + E SMT HF D1 ) around 0.05. Hence, the cycle achieves higher rates when the relative concentration of SMTHFD1 is much higher than that of SHMT. We also note the maximum rate calculated from the specified kinetic parameters is much higher than the median obtained from simulations applying a two-fold change in the model kinetic parameters (Fig. S2, red squares) . This could indicate that the kinetic parameters in this pathway have been selected for maximum ATP production. However, since the curve for the observed kinetic parameters is still within the 90% confidence intervals (Fig. S2, red errorbars) we cannot exclude this is just coincidence. Figure 4b . Maximum ATP production rate of cycle in Figure 4b as a function of E SMT HF D1 /(E SHMT + E SMT HF D1 ). The green squares were obtained using the kinetic parameters reported in Table S3 . The red squares and errorbars represent the median and 90% confidence interval over 100 simulated kinetic parameters, where the logarithm of each kinetic parameter was sampled uniformingly from a value two fold lower to a value two fold higher than the value in Table S3 .
